Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Innovate Oncology acquires rights to Capridine-Beta for prostate cancer

April 13, 2005

FDA clears phase I study of systemic administered Reolysin

April 13, 2005

Yondelis receives orphan drug designation for ovarian cancer

April 12, 2005

BrachySil enters full development program for pancreatic cancer

April 12, 2005

Array BioPharma and Genentech expand oncology collaboration

April 12, 2005

Phase II trial studies Ceflatonin in combination with Gleevec for CML

April 12, 2005

Novel anticancer therapeutic agents disclosed in recent patents

April 11, 2005

Discovery of a novel 17beta-HSD1 inhibitor with antitumor activity

April 11, 2005

Novel CYP17 inhibitor shows promise as a treatment for prostate cancer

April 11, 2005

Src kinase inhibitor as a potential preventative therapy for metastasis to bone

April 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...